Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

NCT04340557 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV Infection

Interventions

DRUG: Losartan

Sponsor

Sharp HealthCare